Liquidity Ratio Analysis of Steris Corporation: Financial Health
VerifiedAdded on 2023/04/21
|8
|1526
|341
Report
AI Summary
This report focuses on analyzing the financial health of Steris Corporation by examining its liquidity ratios over five years, from 2014 to 2018. Steris, a leading provider of infection prevention and procedural products, primarily serves pharmaceutical, healthcare, and medical device customers. The analysis includes the computation and interpretation of the current ratio, quick ratio, and debt-equity ratio. The current ratio, ranging between 2 and 3, indicates the company's ability to comfortably meet short-term obligations. The quick ratio, between 1.8 and 2.1, further supports this, showing strong liquidity even when excluding less liquid assets. The debt-equity ratio improved from 0.82 to 0.62 over the period, indicating a healthier balance between debt and equity. The report concludes that Steris Corporation maintains a stable liquidity position and is well-positioned to meet its financial obligations.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.
1 out of 8